Paramus, New Jersey (Nov.11, 2024) - The 15th World Mitochondria Society (WMS) Annual Meeting on Targeting Mitochondria, was held on October 29-31, 2024 in Berlin, Germany. Dr. Yong Zhao was invited by Dr. Marvin Edeas (Professor of Medicine at the University of Paris, Founder of WMS) to give a presentation as a major speaker at this Congress, titled “Stem Cell Educator Therapy: A New Era in Mitochondrial Transfer and Regeneration”.
Over the last 14 years, Throne Biotechnologies (Throne) has developed a unique and novel procedure designated the Stem Cell Educator (SCE) therapy. International multi-center clinical studies have demonstrated its clinical efficacy and safety of SCE therapy that can fundamentally reverse type 1 diabetes (T1D), alopecia areata (AA) and other autoimmune/inflammatory diseases or aging-associated neurodegenerative diseases through the immune education of SCE therapy at the root causes, which are the mitochondrial dysfunctions at the local or systematic levels. Dr. Zhao updated the current clinical and research progresses of Stem Cell Educator therapy for the treatment of T1D and other autoimmune diseases. SCE therapy holds great promise to revolutionize the treatment of T1D and eliminate the need for lifelong insulin therapy in recent onset subjects, without the safety and ethical concerns associated with conventional immune and stem cell-based approaches. SCE therapy is the leading technology in immunotherapy and mitochondrial transfer to date to safely and efficiently repair and correct the mitochondrial dysfunctions in multiple human diseases caused by the autoimmunity, chronic inflammation and/or aging.
Photo: Dr. Yong Zhao (middle) was together with Dr. Volkmar Weissig (right, Midwestern University, USA, President of the World Mitochondria Society) and Dr. Marvin Edeas (left, Institut Cochin, INSERM U1016, Université de Paris, France, Founder of the World Mitochondria Society).